Titan Pharmaceuticals Inc
NASDAQ:TTNP

Watchlist Manager
Titan Pharmaceuticals Inc Logo
Titan Pharmaceuticals Inc
NASDAQ:TTNP
Watchlist
Price: 4.69 USD -1.82% Market Closed
Market Cap: 4.3m USD

Intrinsic Value

TTNP doesn't have a meaningful market cap.

There is not enough data to reliably calculate the intrinsic value of TTNP.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TTNP Intrinsic Value
Not Available
Base Case Scenario
Compare TTNP to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about TTNP?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Titan Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Titan Pharmaceuticals Inc

Current Assets 2.9m
Cash & Short-Term Investments 2.8m
Receivables 62k
Other Current Assets 30k
Efficiency

Free Cash Flow Analysis
Titan Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Titan Pharmaceuticals Inc

Revenue
0 USD
Operating Expenses
-4.6m USD
Operating Income
-4.6m USD
Other Expenses
-149k USD
Net Income
-4.7m USD
Fundamental Scores

TTNP Profitability Score
Profitability Due Diligence

Titan Pharmaceuticals Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
Sustainable 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
24/100
Profitability
Score

Titan Pharmaceuticals Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

TTNP Solvency Score
Solvency Due Diligence

Titan Pharmaceuticals Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
49/100
Solvency
Score

Titan Pharmaceuticals Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TTNP Price Targets Summary
Titan Pharmaceuticals Inc

There are no price targets for TTNP.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for TTNP is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

TTNP Insider Trading
Buy and sell transactions by insiders